CID 25117126

Defactinib

Structural Information

Molecular Formula
C20H21F3N8O3S
SMILES
CNC(=O)C1=CC=C(C=C1)NC2=NC=C(C(=N2)NCC3=NC=CN=C3N(C)S(=O)(=O)C)C(F)(F)F
InChI
InChI=1S/C20H21F3N8O3S/c1-24-18(32)12-4-6-13(7-5-12)29-19-28-10-14(20(21,22)23)16(30-19)27-11-15-17(26-9-8-25-15)31(2)35(3,33)34/h4-10H,11H2,1-3H3,(H,24,32)(H2,27,28,29,30)
InChIKey
FWLMVFUGMHIOAA-UHFFFAOYSA-N
Compound name
N-methyl-4-[[4-[[3-[methyl(methylsulfonyl)amino]pyrazin-2-yl]methylamino]-5-(trifluoromethyl)pyrimidin-2-yl]amino]benzamide
Related CIDs

2D Structure

compound 2d structure
3
Annotation Hits

58
References

1828
Patents

510.14093 Da
Monoisotopic Mass

1.4
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 511.14821 199.1
[M+Na]+ 533.13015 205.3
[M+NH4]+ 528.17475 199.3
[M+K]+ 549.10409 202.2
[M-H]- 509.13365 197.8
[M+Na-2H]- 531.11560 205.2
[M]+ 510.14038 199.3
[M]- 510.14148 199.3
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

patents stripe